Focusing on inflammation in the treatment of atherosclerosis.
Publication
, Journal Article
Call, JT; Deliargyris, EN; Newby, LK
Published in: Cardiol Rev
2004
Modern-day treatment of atherosclerosis has arisen primarily from an understanding of the epidemiology of the disease rather than its pathophysiology, in that risk factors have traditionally been targeted. Now that the pivotal role of inflammation in the process of atherosclerosis is recognized, it is noteworthy to evaluate the effect of modern therapies on this facet of the disease. This article first reviews the role of inflammation in the pathophysiology of atherosclerosis, and then explores potential mechanisms by which modern-day therapies can modify this inflammation.
Duke Scholars
Published In
Cardiol Rev
DOI
ISSN
1061-5377
Publication Date
2004
Volume
12
Issue
4
Start / End Page
194 / 200
Location
United States
Related Subject Headings
- Tunica Intima
- Risk Factors
- Pyrimidines
- Inflammation
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Exercise
- Evidence-Based Medicine
- Estrogen Replacement Therapy
- Endothelium, Vascular
Citation
APA
Chicago
ICMJE
MLA
NLM
Call, J. T., Deliargyris, E. N., & Newby, L. K. (2004). Focusing on inflammation in the treatment of atherosclerosis. Cardiol Rev, 12(4), 194–200. https://doi.org/10.1097/01.crd.0000111822.34362.71
Call, Jason T., Efthymios N. Deliargyris, and L Kristin Newby. “Focusing on inflammation in the treatment of atherosclerosis.” Cardiol Rev 12, no. 4 (2004): 194–200. https://doi.org/10.1097/01.crd.0000111822.34362.71.
Call JT, Deliargyris EN, Newby LK. Focusing on inflammation in the treatment of atherosclerosis. Cardiol Rev. 2004;12(4):194–200.
Call, Jason T., et al. “Focusing on inflammation in the treatment of atherosclerosis.” Cardiol Rev, vol. 12, no. 4, 2004, pp. 194–200. Pubmed, doi:10.1097/01.crd.0000111822.34362.71.
Call JT, Deliargyris EN, Newby LK. Focusing on inflammation in the treatment of atherosclerosis. Cardiol Rev. 2004;12(4):194–200.
Published In
Cardiol Rev
DOI
ISSN
1061-5377
Publication Date
2004
Volume
12
Issue
4
Start / End Page
194 / 200
Location
United States
Related Subject Headings
- Tunica Intima
- Risk Factors
- Pyrimidines
- Inflammation
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Exercise
- Evidence-Based Medicine
- Estrogen Replacement Therapy
- Endothelium, Vascular